3KS8

Crystal structure of Reston ebolavirus VP35 RNA binding domain in complex with 18bp dsRNA

External Resource: Annotation

Domain Annotation: SCOP/SCOPe Classification
Domain Annotation: SCOP2 Classification
Domain Annotation: ECOD Classification
Domain Annotation: CATH
Protein Family Annotation
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification

Domain Annotation: SCOP/SCOPe Classification SCOP-e Database Homepage

Chains	Domain Info	Class	Fold	Superfamily	Family	Domain	Species	Provenance Source (Version)
D [auth B]	d3ks8b_	Alpha and beta proteins (a+b)	Filoviridae VP35-like	Filoviridae VP35-like	Filoviridae VP35	Filoviridae VP35	REBOV (Reston ebolavirus - Reston ) [TaxId: 129003 ],	SCOPe (2.08)
C [auth A]	d3ks8a_	Alpha and beta proteins (a+b)	Filoviridae VP35-like	Filoviridae VP35-like	Filoviridae VP35	Filoviridae VP35	REBOV (Reston ebolavirus - Reston ) [TaxId: 129003 ],	SCOPe (2.08)
E [auth C]	d3ks8c_	Alpha and beta proteins (a+b)	Filoviridae VP35-like	Filoviridae VP35-like	Filoviridae VP35	Filoviridae VP35	REBOV (Reston ebolavirus - Reston ) [TaxId: 129003 ],	SCOPe (2.08)
F [auth D]	d3ks8d_	Alpha and beta proteins (a+b)	Filoviridae VP35-like	Filoviridae VP35-like	Filoviridae VP35	Filoviridae VP35	REBOV (Reston ebolavirus - Reston ) [TaxId: 129003 ],	SCOPe (2.08)

Domain Annotation: SCOP2 Classification SCOP2 Database Homepage

Chains	Type	Family Name	Domain Identifier	Family Identifier	Provenance Source (Version)
D [auth B]	SCOP2B Superfamily	Ebola VP35 IID-like	8092334	3002590	SCOP2B (2022-06-29)
C [auth A]	SCOP2B Superfamily	Ebola VP35 IID-like	8092334	3002590	SCOP2B (2022-06-29)
E [auth C]	SCOP2B Superfamily	Ebola VP35 IID-like	8092334	3002590	SCOP2B (2022-06-29)
F [auth D]	SCOP2B Superfamily	Ebola VP35 IID-like	8092334	3002590	SCOP2B (2022-06-29)

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
D [auth B]	Filo_VP35	e3ks8B1	A: a+b complex topology	X: Polymerase cofactor VP35 C-terminal RNA binding domain (From Topology)	H: Polymerase cofactor VP35 C-terminal RNA binding domain (From Topology)	T: Polymerase cofactor VP35 C-terminal RNA binding domain	F: Filo_VP35	ECOD (1.6)
C [auth A]	Filo_VP35	e3ks8A1	A: a+b complex topology	X: Polymerase cofactor VP35 C-terminal RNA binding domain (From Topology)	H: Polymerase cofactor VP35 C-terminal RNA binding domain (From Topology)	T: Polymerase cofactor VP35 C-terminal RNA binding domain	F: Filo_VP35	ECOD (1.6)
E [auth C]	Filo_VP35	e3ks8C1	A: a+b complex topology	X: Polymerase cofactor VP35 C-terminal RNA binding domain (From Topology)	H: Polymerase cofactor VP35 C-terminal RNA binding domain (From Topology)	T: Polymerase cofactor VP35 C-terminal RNA binding domain	F: Filo_VP35	ECOD (1.6)
F [auth D]	Filo_VP35	e3ks8D1	A: a+b complex topology	X: Polymerase cofactor VP35 C-terminal RNA binding domain (From Topology)	H: Polymerase cofactor VP35 C-terminal RNA binding domain (From Topology)	T: Polymerase cofactor VP35 C-terminal RNA binding domain	F: Filo_VP35	ECOD (1.6)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
D [auth B]	1.10.8.950	Mainly Alpha	Orthogonal Bundle	Helicase, Ruva Protein	domain 3	CATH (4.3.0)
D [auth B]	2.10.10.70	Mainly Beta	Ribbon	Seminal Fluid Protein PDC-109 (Domain B)	Filoviridae VP35, C-terminal inhibitory domain, beta-sheet subdomain	CATH (4.3.0)
C [auth A]	1.10.8.950	Mainly Alpha	Orthogonal Bundle	Helicase, Ruva Protein	domain 3	CATH (4.3.0)
C [auth A]	2.10.10.70	Mainly Beta	Ribbon	Seminal Fluid Protein PDC-109 (Domain B)	Filoviridae VP35, C-terminal inhibitory domain, beta-sheet subdomain	CATH (4.3.0)
E [auth C]	1.10.8.950	Mainly Alpha	Orthogonal Bundle	Helicase, Ruva Protein	domain 3	CATH (4.3.0)
E [auth C]	2.10.10.70	Mainly Beta	Ribbon	Seminal Fluid Protein PDC-109 (Domain B)	Filoviridae VP35, C-terminal inhibitory domain, beta-sheet subdomain	CATH (4.3.0)
F [auth D]	1.10.8.950	Mainly Alpha	Orthogonal Bundle	Helicase, Ruva Protein	domain 3	CATH (4.3.0)
F [auth D]	2.10.10.70	Mainly Beta	Ribbon	Seminal Fluid Protein PDC-109 (Domain B)	Filoviridae VP35, C-terminal inhibitory domain, beta-sheet subdomain	CATH (4.3.0)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
C [auth A], D [auth B], E [auth C], F [auth D]	PF02097	Filoviridae VP35 (Filo_VP35)	Filoviridae VP35	-	Family

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A [auth E]	5'-R(APGPAPAPGPGPAPGPGPGPAPGPGPGPAPGPGPA)-3'	-	-	-
B [auth F]	5'-R(UPCPCPUPCPCPCPUPCPCPCPUPCPCPUPUPCPU)-3'	-	-	-
C [auth A], D [auth B], E [auth C], F [auth D]	Polymerase cofactor VP35	RNA binding binding organic cyclic compound binding nucleic acid binding	symbiont-mediated perturbation of host cellular process biological process involved in interspecies interaction between organisms response to stimulus symbiont-mediated suppression of host pathogen-associated molecular pattern receptor signaling pathway response to biotic stimulus biological process involved in symbiotic interaction symbiont-mediated suppression of host immune response symbiont-mediated suppression of host innate immune response response to host immune response symbiont-mediated suppression of host defenses symbiont-mediated perturbation of host innate immune response response to host response to external biotic stimulus symbiont-mediated perturbation of host signal transduction pathway symbiont-mediated perturbation of host cellular process biological process involved in interspecies interaction between organisms response to stimulus symbiont-mediated suppression of host pathogen-associated molecular pattern receptor signaling pathway response to biotic stimulus biological process involved in symbiotic interaction symbiont-mediated suppression of host immune response symbiont-mediated suppression of host innate immune response response to host immune response symbiont-mediated suppression of host defenses symbiont-mediated perturbation of host innate immune response response to host response to external biotic stimulus symbiont-mediated perturbation of host signal transduction pathway modulation of process of another organism symbiont-mediated perturbation of host defense response response to host defenses response to other organism symbiont-mediated perturbation of host immune response response to defenses of other organism symbiont-mediated perturbation of host defenses response to external stimulus biological process involved in interaction with host symbiont-mediated suppression of host signal transduction pathway modulation by symbiont of host process cellular process symbiont-mediated suppression of host cytoplasmic pattern recognition receptor signaling pathway via inhibition of IRF7 activity symbiont-mediated suppression of cytoplasmic pattern recognition receptor signaling pathway symbiont-mediated suppression of host cytoplasmic pattern recognition receptor signaling pathway via inhibition of TBK1 activity symbiont-mediated suppression of host cytoplasmic pattern recognition receptor signaling pathway via inhibition of IKBKE activity symbiont-mediated suppression of host toll-like receptor signaling pathway	virion component host cellular component host intracellular part host cell cytoplasm host cell part host intracellular region cellular anatomical entity

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
C [auth A], D [auth B], E [auth C], F [auth D]	IPR031163	Filoviruses VP35 interferon inhibitory domain	Domain
C [auth A], D [auth B], E [auth C], F [auth D]	IPR043061	Filoviruses VP35 interferon inhibitory domain, beta-sheet subdomain	Homologous Superfamily
C [auth A], D [auth B], E [auth C], F [auth D]	IPR002953	Filoviridae VP35 protein	Family
C [auth A], D [auth B], E [auth C], F [auth D]	IPR043060	Filoviruses VP35 interferon inhibitory domain, helical subdomain	Homologous Superfamily

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.